null
SMILES: C[C@@H](NC(=O)c1cn2CC3O[C@@H]4CC[C@H](C4)N3C(=O)c2c(O)c1=O)c1ccc(F)cc1F
InChI Key: InChIKey=HZQGBUQIMZZLDE-VGWNDNRCSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
POU domain, class 2, transcription factor 2 (Homo sapiens (Human)) | BDBM448198 (US10689399, Compound 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc. US Patent | Assay Description The dose dependent inhibition of OCT2 mediated uptake of a model substrate 14C-Tetraethylammonium (TEA) by test compounds was studied in wild-type an... | US Patent US10689399 (2020) | |||||||||||
More data for this Ligand-Target Pair |